Skip to content

Cipla Q2 preview | Consolidated net profit likely to rise 9% YoY

In the year-ago quarter, Cipla benefitted from the surge in sales of COVID-19-related drugs

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish